{
  "request": {
    "url": "https://query2.finance.yahoo.com/ws/insights/v2/finance/insights?lang=en-US&region=US&getAllResearchReports=true&reportsCount=2&symbol=ABBV"
  },
  "response": {
    "ok": true,
    "status": 200,
    "statusText": "OK",
    "headers": {
      "content-type": [
        "application/json"
      ],
      "cache-control": [
        "public, max-age=300, stale-while-revalidate=120"
      ],
      "vary": [
        "Origin,Accept-Encoding"
      ],
      "y-rid": [
        "3beq7ihg9tcb8"
      ],
      "x-yahoo-request-id": [
        "3beq7ihg9tcb8"
      ],
      "x-request-id": [
        "c3e5acd4-7ba6-48f9-b050-3beb80a138fb"
      ],
      "content-encoding": [
        "gzip"
      ],
      "content-length": [
        "1195"
      ],
      "x-envoy-upstream-service-time": [
        "8"
      ],
      "date": [
        "Fri, 14 May 2021 17:20:39 GMT"
      ],
      "server": [
        "ATS"
      ],
      "x-envoy-decorator-operation": [
        "finance-market-analytics-api--mtls-production-bf1.finance-k8s.svc.yahoo.local:4080/*"
      ],
      "age": [
        "1"
      ],
      "strict-transport-security": [
        "max-age=15552000"
      ],
      "referrer-policy": [
        "no-referrer-when-downgrade"
      ],
      "x-frame-options": [
        "SAMEORIGIN"
      ],
      "connection": [
        "close"
      ],
      "expect-ct": [
        "max-age=31536000, report-uri=\"http://csp.yahoo.com/beacon/csp?src=yahoocom-expect-ct-report-only\""
      ],
      "x-xss-protection": [
        "1; mode=block"
      ],
      "x-content-type-options": [
        "nosniff"
      ]
    },
    "bodyJson": {
      "finance": {
        "result": {
          "symbol": "ABBV",
          "instrumentInfo": {
            "technicalEvents": {
              "provider": "Trading Central",
              "sector": "Healthcare",
              "shortTermOutlook": {
                "stateDescription": "Bullish events outweigh bearish events.",
                "direction": "Bullish",
                "score": 1,
                "scoreDescription": "Weak Bullish Evidence",
                "sectorDirection": "Bearish",
                "sectorScore": 1,
                "sectorScoreDescription": "Weak Bearish Evidence",
                "indexDirection": "Bearish",
                "indexScore": 4,
                "indexScoreDescription": "Very Strong Bearish Evidence"
              },
              "intermediateTermOutlook": {
                "stateDescription": "Recent bullish events outweigh bearish events.",
                "direction": "Bullish",
                "score": 2,
                "scoreDescription": "Bullish Evidence",
                "sectorDirection": "Bearish",
                "sectorScore": 1,
                "sectorScoreDescription": "Weak Bearish Evidence",
                "indexDirection": "Bearish",
                "indexScore": 2,
                "indexScoreDescription": "Bearish Evidence"
              },
              "longTermOutlook": {
                "stateDescription": "All events are bullish.",
                "direction": "Bullish",
                "score": 1,
                "scoreDescription": "Weak Bullish Evidence",
                "sectorDirection": "Bullish",
                "sectorScore": 1,
                "sectorScoreDescription": "Weak Bullish Evidence",
                "indexDirection": "Bullish",
                "indexScore": 1,
                "indexScoreDescription": "Weak Bullish Evidence"
              }
            },
            "keyTechnicals": {
              "provider": "Trading Central",
              "support": 107.31,
              "resistance": 116.93,
              "stopLoss": 111.064383
            },
            "valuation": {
              "color": 0,
              "description": "Overvalued",
              "discount": "-48%",
              "relativeValue": "Premium",
              "provider": "Trading Central"
            }
          },
          "companySnapshot": {
            "sectorInfo": "Healthcare",
            "company": {
              "innovativeness": 0.9392,
              "hiring": 0.9244,
              "sustainability": 0.7686,
              "insiderSentiments": 0.1215,
              "earningsReports": 0.9343,
              "dividends": 0.9433
            },
            "sector": {
              "innovativeness": 0.5,
              "hiring": 0.5,
              "sustainability": 0.5,
              "insiderSentiments": 0.5,
              "earningsReports": 0.5,
              "dividends": 0.5
            }
          },
          "recommendation": {
            "targetPrice": 130,
            "provider": "Argus Research",
            "rating": "BUY"
          },
          "events": [
            {
              "eventType": "Relative Strength Index (RSI)",
              "pricePeriod": "D",
              "tradingHorizon": "S",
              "tradeType": "S",
              "imageUrl": "https://s.yimg.com/uc/fin/img/assets/generic.svg",
              "startDate": 1620739800,
              "endDate": 1620739800
            }
          ],
          "reports": [
            {
              "id": "MS_0P0000XPGW_AnalystReport_1620945331000",
              "headHtml": "Analyst Report: AbbVie Inc.",
              "provider": "Morningstar",
              "reportDate": "2021-05-13T22:35:31Z",
              "reportTitle": "AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.",
              "reportType": "Analyst Report"
            },
            {
              "id": "ARGUS_3610_AnalystReport_1620911988000",
              "headHtml": "Analyst Report: AbbVie Inc",
              "provider": "Argus Research",
              "reportDate": "2021-05-13T13:19:48Z",
              "reportTitle": "AbbVie, a research-based biopharmaceutical company, was spun off from Abbott Laboratories in January 2013. The company is based in suburban Chicago. The shares are a component of the S&P 500.",
              "reportType": "Analyst Report"
            }
          ],
          "sigDevs": [
            {
              "headline": "Inventiva: Cash, Cash Equivalents At EUR 107.8 Mln At End-March",
              "date": "2021-05-12"
            }
          ]
        },
        "error": null
      }
    }
  }
}